Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany

Clinical trial NCT01155193 · COMPLETED

Trial details

NCT number: NCT01155193
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Syncytial Virus Infections

Start date: 2002-09-01
Primary completion: 2016-07-31
Enrollment: 30804

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.